• Milestone Pharmaceuticals (NASDAQ:MIST) Earns Buy Rating from HC Wainwright

    Source: Buzz FX / 18 Mar 2025 11:46:16   America/New_York


    Milestone Pharmaceuticals (NASDAQ:MIST) Earns Buy Rating from HC Wainwright Written by MarketBeat March 18, 2025 Share Link copied to clipboard. Remove Ads Milestone Pharmaceuticals ( NASDAQ:MIST - Get Free Report ) 's stock had its "buy" r
    Read more...
Share on,